Abstract:Metabolic engineering of P. pastoris achieves NMN production by semi‐biosynthesis and de novo biosynthesis, which represents the highest yield of de novo synthesis of NMN from basic carbon sources yet reported. β‐Nicotinamide mononucleotide (NMN) is a precursor of NAD+ in mammals. Research on NAD+ has demonstrated its crucial role against aging and disease. Here two technical paths were established for the efficient synthesis of NMN in the yeast Pichia pastoris, enabling the production of NMN from the low‐cost nicotinamide (NAM) or basic carbon sources. The yeast host was systematically modified to adapt to the biosynthesis and accumulation of NMN. To improve the semi‐biosynthesis of NMN from NAM, nicotinamide phosphoribosyltransferases were expressed intracellular to evaluate their catalytic activities. The accumulation of extracellular NMN was further increased by the co‐expression of an NMN transporter. Fine‐tuning of gene expression level produced 72.1 mg/L NMN from NAM in flasks. To achieve de novo biosynthesis NMN, a heterologous biosynthetic pathway was reassembled in yeast cells. Fine‐tuning of pathway nodes by the modification of gene expression level and enhancement of precursor generation allowed efficient NMN synthesis from glucose (36.9 mg/L) or ethanol (57.8 mg/L) in flask. Lastly, cultivations in a bioreactor in fed‐batch mode achieved an NMN titre of 1004.6 mg/L at 165 h from 2 g NAM and 868 g glucose and 980.4 mg/L at 91 h from 160 g glucose and 557 g ethanol respectively. This study provides a foundation for future optimization of NMN biosynthesis by engineered yeast cell factories.

Design and tailoring of an artificial DNA scaffolding system for efficient production of nicotinamide mononucleotide

Structure-guided mining and engineering of nicotinamide riboside kinase for efficient synthesis of nicotinamide mononucleotide

Improvement of an enzymatic cascade synthesis of nicotinamide mononucleotide via protein engineering and reaction-process reinforcement

Synthesis of NMN by cascade catalysis of intracellular multiple enzymes

Systematic Engineering of Escherichia coli for Efficient Production of Nicotinamide Mononucleotide From Nicotinamide

Metabolic Engineering of Bacillus licheniformis for the Bioproduction of Nicotinamide Riboside from Nicotinamide and Glucose

Technology and functional insights into the nicotinamide mononucleotide for human health

Rational Design of Engineered Microbial Cell Surface Multi-Enzyme Co-Display System for Sustainable NADH Regeneration from Low-Cost Biomass.

Rapid Prototyping Enzyme Homologs to Improve Titer of Nicotinamide Mononucleotide Using a Strategy Combining Cell‐free Protein Synthesis with Split GFP

Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide

De novo biosynthesis and nicotinamide biotransformation of nicotinamide mononucleotide by engineered yeast cells

Stoichiometric Regeneration of Biomimetic Nicotinamide Coenzyme Powered by Biomass Sugars via In Vitro Synthetic Enzymatic Biosystems

Exploring the De Novo NMN Biosynthesis as an Alternative Pathway to Enhance NMN Production

Metabolic engineering of Escherichia coli for optimized biosynthesis of nicotinamide mononucleotide, a noncanonical redox cofactor

A novel pH-stat fed-batch strategy to boost the production of nicotinamide mononucleotide by high cell density fermentation

Improving the production of NAD+ via multi-strategy metabolic engineering in Escherichia coli

Whole-cell synthesis of nicotinamide mononucleotide by recombinant Saccharomyces cerevisiae from glucose and nicotinamide

Creating enzymes and self-sufficient cells for biosynthesis of the non-natural cofactor nicotinamide cytosine dinucleotide

Protein engineering of NADH pyrophosphatase for efficient biocatalytic production of reduced nicotinamide mononucleotide

Recent Advances in the Chemical Synthesis of β-Nicotinamide Mononucleotide

Biosynthesis of β-nicotinamide mononucleotide from glucose via a new pathway in Bacillus subtilis